Table: Pharmarise Holdings -2019/20 group results

Pharmarise Holdings

27/07/2020 10:00

Jul 27 (Reuters)- 
          Pharmarise Holdings Corp 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                May 31, 2020    May 31, 2019   May 31, 2021     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             51.03           51.73          54.04        26.24    
                 (-1.3 pct)      (-5.2 pct)     (+5.9 pct)    (+1.9 pct) 
  Operating          1.03          640 mln          1.17       411 mln   
                 (+61.6 pct)     (-45.7 pct)    (+12.8 pct)  (-21.1 pct) 
  Recurring          1.02          590 mln          1.11       383 mln   
                 (+73.3 pct)     (-45.9 pct)    (+8.7 pct)   (-26.7 pct) 
  Net
  Net              577 mln         23 mln         376 mln       70 mln   
                                                (-34.9 pct)  (-88.2 pct) 
  EPS             61.11 yen       2.55 yen       40.51 yen     7.54 yen  
  EPS Diluted     46.38 yen       2.24 yen                               
  Ann Div         14.00 yen       14.00 yen      14.00 yen               
  -Q2 Div            NIL             NIL            NIL                  
  -Q4 Div         14.00 yen       14.00 yen      14.00 yen               
  
  NOTE - Pharmarise Holdings Corp.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T